Abstract | BACKGROUND: STUDY DESIGN: In a clinical research center at a university hospital, 41 patients with dysmenorrhea, nonmenstrual pelvic pain and dyspareunia associated with histologically proven endometriosis were included in an open, prospective, randomized, controlled clinical trial. Twenty-one women were assigned by computer-generated randomization to receive Implanon, and 20 women to receive DMPA. As main outcome measures of this pilot study, we evaluated pain improvement quantified according to visual analog scale score, side effects, vaginal bleeding patterns, withdrawal rate and overall degree of satisfaction. RESULTS: During a follow-up period of 1 year, we ascertained a clear improvement in pain intensity for both treatment options. After 6 months, the average decrease in pain was 68% in the Implanon group and 53% in the DMPA group. The side-effects profile and the overall degree of satisfaction after study termination were comparable for both treatment options. CONCLUSION:
|
Authors | Katharina Walch, Gertrud Unfried, Johannes Huber, Christine Kurz, Michael van Trotsenburg, Elisabeth Pernicka, René Wenzl |
Journal | Contraception
(Contraception)
Vol. 79
Issue 1
Pg. 29-34
(Jan 2009)
ISSN: 1879-0518 [Electronic] United States |
PMID | 19041438
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Contraceptive Agents, Female
- etonogestrel
- Desogestrel
- Medroxyprogesterone Acetate
|
Topics |
- Adult
- Contraceptive Agents, Female
(therapeutic use)
- Desogestrel
(therapeutic use)
- Endometriosis
(physiopathology)
- Female
- Follow-Up Studies
- Humans
- Medroxyprogesterone Acetate
(therapeutic use)
- Middle Aged
- Palliative Care
- Pelvic Pain
(drug therapy, etiology)
- Pilot Projects
- Prospective Studies
- Treatment Outcome
- Young Adult
|